Myomo, Inc.
$0.9
▼
-0.74%
2026-04-21 08:19:00
myomo.com
ASE: MYO
Explore Myomo, Inc. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$34.65 M
Current Price
$0.9
52W High / Low
$4.99 / $0.6
Stock P/E
—
Book Value
$0.3
Dividend Yield
—
ROCE
-47.54%
ROE
-86.24%
Face Value
—
EPS
$-0.37
Exp Qtr EPS
—
Sector
Healthcare
Industry
Medical Devices
Employees
194
Beta
1.16
Debt / Equity
169.97
Current Ratio
3.3
Quick Ratio
2.93
Forward P/E
-2.63
Price / Sales
0.65
Enterprise Value
$27.56 M
EV / EBITDA
-2.04
EV / Revenue
0.67
Rating
None
Target Price
$4.32
EPS Forecast (FY)
—
Pros
- Short-term liquidity looks comfortable.
- Valuation is not stretched on P/E basis.
Cons
- Return on equity is on the weaker side.
- Capital efficiency is modest.
- Leverage is relatively high.
- Operating margin is thin.
- Net margin is relatively low.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | Abbott Laboratories | $93.07 | 25.91 | $162.16 B | 2.6% | 11.47% | 12.96% | $139.06 / $93.92 | $30.02 |
| 2. | CapsoVision, Inc. | $6.01 | — | $299.53 M | — | -185.75% | -1.85% | $15.37 / $3.43 | $0.28 |
| 3. | Treace Medical Concepts, Inc. | $1.97 | — | $125.31 M | — | -33.86% | -58.94% | $7.78 / $1.17 | $1.37 |
| 4. | SI-BONE, Inc. | $14.32 | — | $632.45 M | — | -10.47% | -10.97% | $21.89 / $12.15 | $4.07 |
| 5. | UFP Technologies, Inc. | $201.08 | 22.53 | $1.54 B | — | 16.02% | 17.82% | $274.93 / $182.87 | $54.95 |
| 6. | iTonic Holdings Ltd. | $0.32 | — | $5.41 M | — | -59.82% | -71.25% | $32 / $0.25 | $0.36 |
| 7. | ClearPoint Neuro, Inc. | $11.16 | — | $349.74 M | — | -27.78% | -95.64% | $30.1 / $8.27 | $0.95 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|
| Sales | 11.35 M | 10.09 M | 9.65 M | 9.83 M | 12.07 M | — |
| Operating Profit | -2.77 M | -3.52 M | -4.59 M | -3.52 M | -0.25 M | — |
| Net Profit | -3.81 M | -3.66 M | -4.63 M | -3.47 M | -0.26 M | — |
| EPS in Rs | -0.1 | -0.1 | -0.12 | -0.09 | -0.01 | -0.03 |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 40.93 M | 32.55 M | 19.24 M | 15.56 M |
| Operating Profit | -14.4 M | -6.21 M | -8.23 M | -10.67 M |
| Net Profit | -15.57 M | -6.18 M | -8.15 M | -10.72 M |
| EPS in Rs | -0.4 | -0.16 | -0.21 | -0.28 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 38.64 M | 42.24 M | 14.58 M | 10.16 M |
| Total Liabilities | 27.23 M | 17.53 M | 5.59 M | 3.8 M |
| Equity | 11.4 M | 24.71 M | 8.99 M | 6.36 M |
| Current Assets | 27.56 M | 32.79 M | 13.65 M | 9.22 M |
| Current Liabilities | 8.35 M | 10.17 M | 5.48 M | 3.6 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | -14.51 M | -3.29 M | -6.17 M | -10.23 M |
| Investing CF | -7.06 M | 0.26 M | -2.03 M | -0.31 M |
| Financing CF | 11.43 M | 20.93 M | 9.71 M | 0.38 M |
| Free CF | -17.84 M | -4.65 M | -6.32 M | -10.35 M |
| Capex | -3.33 M | -1.36 M | -0.15 M | -0.11 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | 69.17% | 23.7% | — | — |
| Earnings Growth % | 24.1% | 24% | — | — |
| Profit Margin % | -19% | -42.34% | -68.92% | — |
| Operating Margin % | -19.07% | -42.78% | -68.61% | — |
| Gross Margin % | 71.23% | 68.51% | 65.91% | — |
| EBITDA Margin % | -16.68% | -40.09% | -65.12% | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
No stock split history available.